Institut de recherche biomédicale
     
    Vous êtes ici : Accueil / Animation / Symposium / Programme

    Programme

    •  

    08:45 a.m.      Welcome: Pierre-Olivier Couraud, Institut Cochin, Paris, France
    09:00 a.m.      Introduction: Chahrazade Kantari-Mimoun, Emmanuel Donnadieu, Institut Cochin, Paris, France

     

    CAR T cells in hematological malignancies

    Chair: Chahrazade Kantari-Mimoun, Institut Cochin, Paris, France and Jean-Christophe Bories, Hôpital Saint-Louis, Paris, France

    09:00 a.m.      CAR T cell therapy: Challenges and opportunities - Jessica Hartmann, Paul-Ehrlich-Institut, Langen, Germany
    09:30 a.m.      Precision T cell engineering to improve CAR therapy - Justin Eyquem, Memorial Sloan Kettering Cancer Center, New York, USA
    10:00 a.m.      Allogeneic CAR T cell therapy: On the way to “off-theshelf” products for hematological malignancies - Ibtissam Marchiq, Servier, Paris, France

    10:30 a.m. Coffee break

     

    CAR T cells in solid tumors I

    Chair: Diane Damotte, Hôpital Cochin, Paris, France and Emmanuel Donnadieu, Institut Cochin, Paris, France

    11:00 a.m.      Adoptive transfer of T cells: Combinatorial strategies to treat solid tumor - Reno Debets, Erasmus MC, Rotterdam, The Netherlands
    11:30 a.m.      CAR T cells for solid tumors: Phase I intra-tumoral delivery to head and neck cancer - Lynsey Whilding, King’s College, London, United Kingdom
    12:00 p.m.      Integration of CAR T cells into the treatment of leukemias and other cancers - Claudia Rössig, University of Munster, Germany

    12:30 p.m. Lunch

     

    CAR T cells in solid tumors II

    Chair: Nadège Bercovici, Institut Cochin, Paris, France and Jessica Hartmann, Paul-Ehrlich-Institut, Langen, Germany

    14:00 p.m.      Imaging CAR T cells in human solid tumors - Chahrazade Kantari-Mimoun, Institut Cochin, Paris, France
    14:30 p.m.      Cellular interactions regulating CAR T cell anti-tumor activity in vivo - Philippe Bousso, Institut Pasteur, Paris, France
    15:00 p.m.      Integrating the unexpected roles of T cells in cardiovascular and oncological pathology: Clues for cardiotoxicity in tumor therapy - Marinos Kallikourdis, Humanitas Research Hospital,Milan, Italy

    15:30 p.m. Coffee break

     

    CAR T cells: Future directions

    Chair: Véronique Blanc, Servier, Paris, France and Emmanuel Donnadieu, Institut Cochin, Paris, France

    16:00 p.m.      CARs, TRUCKs and beyond - Hinrich Abken, University of Cologne, Germany
    16:30 p.m.      Chimeric antigen receptor macrophages for cancer immunotherapy - Michael Klichinsky, University of Pennsylvania, Philadelphia, USA
    17:00 p.m.      Controlling the intracellular transport to modulate CAR T efficacy - Franck Perez, Institut Curie, Paris, France

    17:30 p.m.      Closing remarks